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Training in Nuclear Cardiology
Nuclear cardiology (Table 1) provides important diagnostic
and prognostic information that is an essential part of the
knowledge base required of the well-trained cardiologist for
optimal management of the cardiovascular patient. Training
of fellows in nuclear cardiology is divided into 3 levels:*
• General (Level 1, 2 months): Makes trainee conversant
with the field of nuclear cardiology for application in
general clinical management of cardiovascular patients.
• Specialized (Level 2, 4, to 6 months): Provides trainee with
special expertise to practice clinical nuclear cardiology.†
• Advanced (Level 3, 1 year): Provides advanced training
sufficient to pursue an academic career or direct a nuclear
cardiology laboratory.†
General Cardiology Training Background
To have an adequate understanding of the clinical applica-
tions of nuclear cardiology and to perform tests safely, the
cardiology trainee must acquire knowledge and proficiency
in the following areas of general cardiology:
1. Coronary angiography and physiology
2. Cardiac physiology and pathophysiology
3. Rest and exercise electrocardiography
4. Exercise physiology
5. Pharmacology of standard cardiovascular drugs
6. Cardiopulmonary resuscitation and treatment of other
cardiac emergencies
7. Pharmacology and physiology of commonly used stress
agents, such as dipyridamole, adenosine, and dobutamine
8. Clinical outcomes assessment
Overview of Nuclear Cardiology Training
Training in nuclear cardiology at all levels should provide an
understanding of the indications and appropriate use of
specific nuclear cardiology tests, the safe use of radionu-
clides, basics of instrumentation and image processing,
methods of quality control, image interpretation, integra-
tion of risk factors, clinical symptoms and stress testing, and
the appropriate application of the resultant diagnostic in-
formation for clinical management. The depth of under-
standing will vary with each of the 3 levels of training.
Training in nuclear cardiology is best acquired in Accredi-
tation Council for Graduate Medical Education (ACGME)-
approved training programs in cardiology, nuclear medicine,
or radiology. An exception to this ACGME requirement is
the didactic and laboratory training in radiation safety and
radioisotope handling that may be provided by qualified
physicians/scientists in a non-ACGME program when such
The recommendations of this Joint Task Force, made up of representatives of the
American College of Cardiology Foundation (ACCF) and the American Society of
Nuclear Cardiology (ASNC), have been approved by the governing bodies of the
ACCF and ASNC in October 2007.
*The issues of ongoing clinical competence and training or retraining of practicing
cardiologists are beyond the scope of this document. The Certification Board of
Nuclear Cardiology (CBNC) was established jointly by the American College of
Cardiology and ASNC and assesses knowledge and mastery in the areas of radiation
safety and the technical and clinical performance of nuclear cardiology procedures. For
additional information, contact CBNC at 19562 Club House Road, Montgomery
Village, MD 20886; http://www.cbnc.org.
†Level 2 and Level 3 training meet eligibility criteria for taking the Certification
Board of Nuclear Cardiology examination and Nuclear Regulatory Commission
(NRC) training and experience requirements to become an authorized user. The
NRC establishes federal policy with regard to the medical use of nuclear reactor
byproduct materials. Currently, there are 33 states that have applied and been
approved by the NRC to self-regulate the use of radioactive materials, so called
“Agreement States.” The other 17 states and the District of Columbia are regulated
by the federal policy. There is variation within the Agreement States in the training
and experience requirements for physicians applying to become authorized users of
radioactive materials for diagnostic testing. The NRC requires only that the
Agreement State requirements be as stringent as the federal NRC policy, but states
have the authority to make the requirements more stringent. Some states require a
greater number of total hours for the didactic, classroom, and laboratory experience in
radiation safety. Other states have restricted the acceptable programs or institutions
where such training hours may be acquired. Given this variability in training and
experience requirements within the U.S., trainees are advised to contact the NRC and
the Agreement States where they may seek to become authorized users of radioactive
materials for the current rules and requirements. For details contact the Agreement
States Homepage at http://www.hsrd.ornl.gov/nrc/home.html. Click on Directory
and then click on Directory of Agreement States and Non-Agreement State Directors
and State Liaison Officers. This will provide information on contacting the individual
states and getting the specific licensure requirements.
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a program is not available as part of the clinical ACGME
training program. For laboratories that provide training to
cardiology fellows, accreditation by the Intersocietal Com-
mission for Accreditation of Nuclear Laboratories
(ICANL) is also recommended.
Nuclear cardiology training consists of the components
shown in Table 2. Didactic, clinical case experience, and
hands-on training hours require documentation in a log-
book, having the trainee’s name appear on the clinical report
or having some other specific record. The hours need to be
monitored and verified by the nuclear cardiology training
preceptor. For the advanced trainee, specialized training and
research can be derived as part of an established program in
either cardiology or a division of nuclear medicine. The
person(s) responsible for the didactic, clinical, and hands-on
training and experience are responsible for evaluating the
competence of the trainee in nuclear cardiology upon
completion of the program. This can be accomplished by
observing the daily performance of the fellow, a formal
testing procedure, or both. The preceptor for Level 2 or
Level 3 should be an authorized user recognized by the
Nuclear Regulatory Commission (NRC) or an Agreement
State, have Level 3 (or the equivalent) training in nuclear
cardiology, and preferably be certified by the Certification
Board of Nuclear Cardiology (CBNC).
Didactic Program
Lectures and self-study. This component consists of
lectures on the basic aspects of nuclear cardiology and
parallel self-study material consisting of reading and
viewing cases on video or CD-ROM. The lectures and
reading should provide the fellow with an understanding
of the clinical applications of nuclear cardiology, includ-
ing imaging with positron-emitting radionuclides and
computed tomography (CT) hybrid systems including
single-photon emission computed tomography (SPECT)/CT
and positron emission tomography (PET)/CT. The mate-
rial covered should include radiopharmaceuticals, radiation
physics instrumentation, nuclear cardiology diagnostic tests
and procedures/protocols, general cardiology as it relates to
image interpretation, risk stratification, myocardial perfu-
sion imaging, ventricular function imaging, and assessment
of myocardial viability. Specificity, sensitivity, diagnostic
accuracy, utility in assessing prognoses and interventions,
costs, indications, and pitfalls in interpretation and clinical
application must be emphasized for each patient subset.
This program may be scheduled over a 12- to 24-month
period, concurrent with other fellowship assignments. Some of
the information can be effectively transmitted as part of a
weekly noninvasive or invasive cardiology conference with
presentation and discussion of nuclear cardiology image data.
Radiation safety. The second component of the didactic
program should provide the fellow with an understanding of
radiation safety as it relates to patient selection and admin-
istration of radiopharmaceuticals and utilization of CT
systems. Fellows seeking Level 2 or Level 3 training will
require greater in-depth knowledge as well as hands-on
practical experience. These requirements are detailed for
each level of training.
Interpretation of Clinical Cases
During training, fellows should actively participate in daily
nuclear cardiology study interpretation under the direction
of a qualified preceptor in nuclear cardiology. For all studies
in which angiographic or hemodynamic data are available,
such information should be correlated with the nuclear
Classification of Nuclear Cardiology Procedures
Table 1 Classification of Nuclear Cardiology Procedures
1. Standard nuclear cardiology procedures
a. Myocardial perfusion imaging
i. SPECT with technetium-99m agents and/or thallium-201, with or without attenuation correction
ii. PET with rubidium-82 and/or nitrogen-13 ammonia
iii. Planar with technetium-99m agents and/or thallium-201
iv. ECG gating of perfusion images for assessment of global and regional ventricular function
v. Imaging protocols
vi. Stress protocols
1. Exercise stress
2. Pharmacologic stress
vii. Viability assessment including reinjection and delayed imaging of thallium-201 and/or metabolic imaging where available
b. Equilibrium radionuclide angiocardiography and/or “first-pass” radionuclide angiography at rest
c. Qualitative and quantitative methods of image display and analysis
2. Less commonly used nuclear cardiology procedures
a. Combined myocardial perfusion imaging with cardiac CT for attenuation correction or anatomic localization
b. Equilibrium radionuclide angiocardiography and/or “first-pass” radionuclide angiography during exercise or pharmacologic stress
c. Metabolic imaging using single-photon and/or positron-emitting radionuclides
d. Myocardial infarct imaging
e. Cardiac shunt studies
CT  computed tomography; ECG  electrocardiogram; PET  positron emission tomography; SPECT  single-photon emission computed tomography.
Nuclear Cardiology Training Components
Table 2 Nuclear Cardiology Training Components
1. Didactic program
a. Lectures and self-study
b. Radiation safety
2. Interpretation of clinical cases
3. Hands-on experience
a. Clinical cases
b. Radiation safety
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cardiology studies. Although experience in all aspects of
nuclear cardiology is recommended, some procedures may
not be available—or may be performed in low volume—in
some training programs. Under such circumstances, an
adequate background for general fellowship training can be
satisfied with appropriate reading or review of case files.
Training in nuclear cardiology needs to include extensive
experience with the standard nuclear cardiology procedures
and as much exposure as possible with the less commonly
performed procedures. The training program needs to provide
a teaching file consisting of perfusion and ventricular function
studies with angiographic documentation of disease.
Hands-On Experience
Clinical cases. Fellows should have hands-on supervised
experience in an appropriate number of the standard pro-
cedures (e.g., myocardial perfusion imaging and radionu-
clide angiography) and as many of the less commonly
performed procedures as possible. Such experience should
include pre-test patient evaluation; radiopharmaceutical
preparation—measuring the dose, administration, and ex-
perience with relevant radionuclide generators; operation
and quality control of planar and SPECT gamma camera
and PET and CT systems; setup of the imaging computer;
utilization of ECG gating; performing treadmill, bicycle,
and pharmacologic stress testing techniques; processing the
data for display; interpreting the study; and generating a
clinical report. Complete nuclear cardiology studies should
be performed under the supervision of qualified personnel.
Radiation safety. Fellows need to be familiar with radia-
tion biology and the regulations governing the use of
radioactive materials and ionizing radiation for performing
diagnostic nuclear cardiology and hybrid CT studies. This
knowledge includes details for protecting patients, the
public, and the user from the effects of radiation.
General Training—Level 1
(Minimum of 2 Months)
The trainee is exposed to the fundamentals of nuclear
cardiology for a minimum period of 2 months during
training. This 2-month experience provides familiarity with
nuclear cardiology technology and its clinical applications in
the general clinical practice of adult cardiology, but it is not
sufficient for the specific practice of nuclear cardiology. The
3 components of training include a didactic program that
includes lectures, self-study, radiation safety and regula-
tions, interpretation of nuclear cardiology studies, and
hands-on experience.
Didactic Program
Lectures and self-study. This component consists of lec-
tures on the basic aspects of nuclear cardiology and parallel
self-study material consisting of reading and viewing case
files. The material presented should integrate the role of
nuclear cardiology into total patient management. Such
information can be included within a weekly noninvasive or
invasive cardiology conference, with presentation and dis-
cussion of nuclear cardiology image data as part of diagnos-
tic and therapeutic management.
Knowledge and appreciation of radiation safety. The
didactic program should include reading and practical ex-
perience with the effects of radiation and provide the fellow
with an understanding of radiation safety as it relates to
patient selection and administration of radiopharmaceuti-
cals and utilization of CT systems.
Interpretation of Nuclear Cardiology Studies
During the 2-month rotation, fellows should actively par-
ticipate in daily nuclear cardiology study interpretation
(minimum of 100 cases). Experience in all the areas listed in
Table 1 is recommended. If some procedures are not
available or are performed in low volume, an adequate
background for general fellowship training can be satisfied
by appropriate reading or review of case files. The teaching
file should consist of perfusion and ventricular function
studies with angiographic/cardiac catheterization documen-
tation of disease.
Hands-On Experience
Fellows should perform complete nuclear cardiology studies
alongside a qualified technologist or other qualified labora-
tory personnel. They should, under supervision, observe and
participate in a large number of the standard procedures and
as many of the less commonly performed procedures as
possible. Fellows should have experience in the practical
aspects of radiation safety associated with performing clin-
ical patient studies.
Specialized Training—Level 2
(Minimum of 4 Months)
Fellows who wish to practice the specialty of nuclear
cardiology are required to have at least 4 months of training.
Level 2 training includes a minimum of 700 h of radiation
safety experience in nuclear cardiology. There needs to be
didactic, clinical study interpretation, and hands-on involve-
ment in clinical cases. In training programs with a high
volume of procedures, clinical experience may be acquired in
as short a period as 4 months. In programs with a lower
volume of procedures, a total of 6 months of clinical
experience will be necessary to achieve Level 2 competency.
The additional training required of Level 2 trainees is to
enhance their clinical skills, knowledge, and hands-on
experience in radiation safety and qualify them to become
authorized users of radioactive materials in accordance with
the regulations of the NRC and/or the Agreement States.†
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Didactic
Lectures and self-study. The didactic training should
include in-depth details of all aspects of the procedures
listed in Table 1. This program may be scheduled over a 12-
to 24-month period concurrent and integrated with other
fellowship assignments.
Radiation safety. Classroom and laboratory training needs
to include extensive review of radiation physics and instru-
mentation, radiation protection, mathematics pertaining to
the use and measurement of radioactivity, chemistry of
byproduct material for medical use, radiation biology, the
effects of ionizing radiation, and radiopharmaceuticals.
There should be a thorough review of regulations dealing
with radiation safety for the use of radiopharmaceuticals and
ionizing radiation. This experience should total a minimum
of 80 h and be separately documented.
Interpretation of Clinical Cases
Fellows should participate in the interpretation of all nuclear
cardiology imaging data for the 4- to 6-month training
period. It is imperative that the fellows have experience in
correlating catheterization or CT angiographic data with
radionuclide-derived data for a minimum of 30 patients. A
teaching conference in which the fellow presents the clinical
material and nuclear cardiology results is an appropriate
forum for such experience. A total of 300 cases should be
interpreted under preceptor supervision, from direct patient
studies (Table 3).
Hands-On Experience
Clinical cases. Fellows acquiring Level 2 training should
have hands-on supervised experience with a minimum of 35
patients: 25 patients with myocardial perfusion imaging and
10 patients with radionuclide angiography. Such experience
should include pre-test patient evaluation; radiopharmaceu-
tical preparation (including experience with relevant radio-
nuclide generators and CT systems); performance of studies
with and without attenuation correction; administration of
the dosage, calibration, and setup of the gamma camera and
CT system; setup of the imaging computer; processing the
data for display; interpretation of the studies; and generating
clinical reports.
Radiation safety work experience. This experience should
total 620 h and be acquired during training in the clinical
environment where radioactive materials are being used and
under the supervision of an authorized user who meets the
NRC requirements of Part 35.290 or Part 35.290(c)(ii)(G)
and Part 35.390 or the equivalent Agreement State require-
ments, and must include:
a. Ordering, receiving, and unpacking radioactive materials
safely and performing the related radiation surveys;
b. Performing quality control procedures on instruments
used to determine the activity of dosages and per-
forming checks for proper operation of survey meters;
c. Calculating, measuring, and safely preparing patient or
human research subject dosages;
d. Using administrative controls to prevent a medical event
involving the use of unsealed byproduct material;
e. Using procedures to safely contain spilled radioactive
material and using proper decontamination procedures;
f. Administering dosages of radioactive material to pa-
tients or human research subjects; and
g. Eluting generator systems appropriate for preparation
of radioactive drugs for imaging and localization
studies, measuring and testing the eluate for radionu-
clide purity, and processing the eluate with reagent
kits to prepare labeled radioactive drugs.
Additional Experience
The training program for Level 2 must also provide expe-
rience in computer methods for analysis. This should
include perfusion and functional data derived from thallium
or technetium agents and ejection fraction and regional wall
motion measurements from radionuclide angiographic studies.
Advanced Training—Level 3
(Minimum of 1 Year)
For fellows planning an academic career in nuclear cardiol-
ogy or a career directing a clinical nuclear cardiology
laboratory, an extended program is required. This may be
part of the standard 3-year cardiology fellowship. In addi-
tion to the recommended program for Level 2, the Level 3
program should include advanced quality control of nuclear
cardiology studies and active participation and responsibility
in ongoing laboratory or clinical research. In parallel with
participation in a research program, the trainee should
participate in clinical imaging activities for the total training
period of 12 months, to include supervised interpretative
experience in a minimum of 600 cases. Hands-on experi-
ence should be similar to, or greater than, that required for
Level 2 training. The fellow should be trained in most of the
following areas:
• Qualitative interpretation of standard nuclear cardiology
studies, including SPECT and/or PET myocardial perfu-
sion imaging, ECG-gated perfusion studies, attenuation-
corrected studies, gated-equilibrium studies, “first-pass,”
Summary of Training Requirementsfor Nuclear Cardiology
Table 3 Summary of Training Requirementsfor Nuclear Cardiology
Level
Minimum Duration of
Training (Months)
Total No. of
Examinations
1 2 100*
2 4–6 300*
3 12 600*
*A minimum of 35 cases with hands-on experience must be performed and interpreted under
supervision.
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and any of the less commonly performed procedures
available at the institution
• Quantitative analysis of SPECT and/or PET myocardial
perfusion and/or metabolic studies
• Quantitative radionuclide angiographic and gated-
myocardial perfusion analyses, including measurement of
global and regional ventricular function
• SPECT and/or PET perfusion acquisition, reconstruc-
tion, and display
• ECG-gated SPECT and/or perfusion acquisition, anal-
ysis, and display of functional data
• Imaging of positron-emitting tracers using dedicated
PET systems or hybrid PET/CT systems
The requirements for Level 1 to 3 training in nuclear
cardiology are summarized in Table 3.
Specific Training in Cardiac Imaging of
Positron-Emitting Radionuclides
Cardiac PET and PET/CT imaging of positron-emitting
radionuclides are part of nuclear cardiology. An increasing
number of nuclear laboratories have access to both conven-
tional SPECT and PET imaging. For institutions that have
positron-imaging devices, training guidelines are appropri-
ate. Training in this particular imaging technology should
go hand-in-hand and may be concurrent with training in
conventional nuclear cardiology. Such training should in-
clude those aspects that are unique or specific to the imaging
of positron-emitting radionuclides. Depending on the de-
sired level of expertise, training in cardiac PET and imaging
with positron-emitting radionuclides should include knowl-
edge of substrate metabolism in the normal and diseased
heart; knowledge of positron-emitting tracers for blood
flow, metabolism and neuronal activity, medical cyclotrons,
radioisotope production, and radiotracer synthesis; and
principles of tracer kinetics and their in vivo application for
the noninvasive measurements of regional, metabolic, and
functional processes. The training should also include the
physics of positron decay, aspects of imaging instrumenta-
tion specific to the imaging of positron emitters and the use
of CT, production of radiopharmaceutical agents, quality
control, handling of ultra-short life radioisotopes, appropri-
ate radiation protection and safety, and regulatory aspects.
Consistent with the training guidelines for general nu-
clear cardiology, training should be divided into 3 classes.
General Training (2 Months)
This level is for cardiology fellows who are associated with
an institution where PET and/or PET/CT devices are
available and who wish to become conversant with cardiac
positron imaging. Training should therefore be the same as
for Level 1 training in nuclear cardiology but should include
aspects specific to cardiac positron imaging. The additional
proficiency to be acquired by physician trainees includes
background in substrate metabolism, patient standardiza-
tion and problems related to diabetes mellitus and lipid
disorders, positron-emitting tracers of flow and metabolism,
and technical aspects of positron and CT imaging. A
didactic program should include the interpretation of car-
diac PET studies of myocardial blood flow and substrate
metabolism, the interpretation of studies combining
SPECT for evaluation of blood flow with PET for evalua-
tion of metabolism, the evaluation of diagnostic accuracy
and cost-effectiveness of viability assessment of coronary
artery disease detection, and the understanding of radiation
safety as specifically related to positron emitters. Hands-on
experience should include supervised observation and inter-
pretation of cardiac studies performed with positron-
emitting radionuclides and PET and PET/CT imaging
devices.
Specialized Training (Minimum of 4 Months)
This level of training is for fellows who wish to perform and
interpret cardiac PET or positron imaging studies in addi-
tion to nuclear cardiology. This training should include all
Level 1 and Level 2 training in nuclear cardiology (4 to 6
months) as well as general training for cardiac PET and
PET/CT. Specific aspects of training for PET and for using
positron-emitting radionuclides should include radiation
dosimetry, radiation protection and safety, dose calibration,
physical decay rates of radioisotopes, handling of large doses
of high-energy radioactive materials of short physical half-
lives, quality assurance procedures, and NRC safety and
record-keeping requirements. This level of training requires
direct patient experience with a minimum of 40 patient
studies of myocardial perfusion, metabolism, or both.
Advanced Training (Minimum 1 Year)
This level of training is intended for fellows planning an
academic career in cardiac PET or who wish to direct a
clinical cardiac PET laboratory. Similar to Level 3 training
in nuclear cardiology, this training should include active
participation in laboratory and clinical research in parallel
with clinical activities.
In addition to the requirements for general and special-
ized cardiac PET training (including standard nuclear
cardiology training, as previously described), advanced
training should include the following:
1. Basic principles of cyclotrons, isotope production, ra-
diosynthesis, tracer kinetic principles and models, car-
diac innervation and receptors, and methods for quan-
tifying regional myocardial blood flow and substrate
metabolism.
2. Imaging instrumentation including dedicated PET sys-
tems, hybrid PET/CT systems and SPECT-like positron
imaging devices with high-energy photon collimators or
coincidence detection. Image acquisition and processing
to include review of sinograms, errors in image recon-
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struction, correction routines for photon attenuation,
and patient misalignment.
3. Tissue kinetics of positron-emitting tracers; in vivo
application of tracer kinetic principles; tracer kinetic
models, generation of tissue time–activity curves, and
computer-assisted calculation of region of functional
processes of the myocardium.
4. Computer-assisted data manipulation, quantitative im-
age analysis, and image display.
Hybrid Computed Tomography Imaging
Hybrid imaging devices combining PET or SPECT with
CT are playing an increasing role in the field of cardiac
imaging. Currently, nearly all PET scanners are sold as
PET/CT devices, and SPECT/CT machines are now
available from most manufacturers. As these devices become
more widely disseminated, it will be important that training
guidelines for their use be developed both for fellows in
training and cardiologists already in practice. The applica-
tions of hybrid imaging in cardiology include the use of CT
scanning to provide robust attenuation correction of
SPECT or PET and to assess coronary calcium as a marker
of coronary atherosclerosis. Even these noncontrast appli-
cations of hybrid imaging will require additional training
beyond that required for CT alone. With CT coronary
calcium and SPECT or PET perfusion assessments, addi-
tional training will be needed regarding discordant results.
With contrast injection, high resolution CT coronary an-
giography can be combined with rest/stress assessments of
myocardial perfusion provided by PET and SPECT, allow-
ing functional assessment of the anatomic findings. The
specifics of the training required in hybrid imaging are
beyond the scope of this document; nonetheless, those
nuclear cardiology training programs that are equipped to
perform hybrid imaging should incorporate training in this
field in their programs. Training should include the physics
of hybrid systems, CT attenuation correction, principles and
application of CT coronary calcium assessment, and prin-
ciples and application of CT coronary angiography.
This is an update of the 2006 document that was written
by Manuel D. Cerqueira, MD, FACC—Chair; Daniel
S. Berman, MD, FACC; Marcelo F. Di Carli, MD,
FACC; Heinrich R. Schelbert, MD, PhD, FACC; Frans
J. Th. Wackers, MD, PhD, FACC; and Kim Allan Wil-
liams, MD, FACC (American Society of Nuclear Cardiology
Representative).
doi:10.1016/j.jacc.2007.11.013
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APPENDIX 1. AUTHOR RELATIONSHIPS WITH INDUSTRY—ACCF 2008 RECOMMENDATIONS FOR TRAINING IN
ADULT CARDIOVASCULAR MEDICINE CORE CARDIOLOGY TRAINING (COCATS 3)—TASK FORCE 5: TRAINING IN
NUCLEAR CARDIOLOGY
Name Consultant
Research
Grant
Scientific Advisory
Board
Speakers’
Bureau
Steering
Committee
Stock
Holder Other
Dr. Daniel S.
Berman
● Tyco-Mallinckrodt ● Astellas
● Bristol-Myers Squibb
● GE Healthcare
● Spectrum Dynamics None None ● Spectrum
Dynamics
● Cedars-Sinai
Medical Center
(Software
royalties)
Dr. Manuel D.
Cerqueira
None ● GE Healthcare ● Bristol-Myers Squibb
● CV Therapeutics
● Astellas
● Bristol-Myers Squibb
● CV Therapeutics
● GE Healthcare
● Mallinckrodt
None None None
Dr. Marcelo F. Di
Carli
● Bracco
● Bristol-Myers
Squibb Imaging
● GE Healthcare
● Astellas
● Bracco
● Bristol-Myers Squibb
Imaging
● GE Healthcare
● Bracco
● Bristol-Myers Squibb
Imaging
● GE Healthcare
● Astellas
● Bracco
● GE Healthcare
None None None
Dr. Heinrich R.
Schelbert
None None None None None None None
Dr. Frans J. Th.
Wackers
● Acusphere
● GE Healthcare
● Acusphere
● Astellas
● Bristol-Myers Squibb
● GE Healthcare
● King
Pharmaceuticals
None None None None
Dr. Kim Allan
Williams
● King
Pharmaceuticals
● Bristol-Myers Squibb
● CV Therapeutics
● GE Healthcare
● Bristol-Myers Squibb
● GE Healthcare
● Astellas
● GE Healthcare
None None None
This table represents the relationships of committee members with industry that were reported by the authors as relevant to this topic. It does not necessarily reflect relationships with industry at the time
of publication.
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APPENDIX 2. PEER REVIEWER RELATIONSHIPS WITH INDUSTRY—ACCF 2008 RECOMMENDATIONS FOR
TRAINING IN ADULT CARDIOVASCULAR MEDICINE CORE CARDIOLOGY TRAINING (COCATS 3)—TASK FORCE 5:
TRAINING IN NUCLEAR CARDIOLOGY
Name* Affiliation Consultant
Research
Grant
Scientific Advisory
Board
Speakers’
Bureau
Steering
Committee
Stock
Holder Other
Dr. David J.
Clardy
● Official–Board of
Trustees
None None None None None None None
Dr. Rick A.
Nishimura
● Official–Board of
Governors
None None None None None None None
Dr. James A.
Arrighi
● Organizational–American
Society of Nuclear
Cardiology
None None None None None None None
Dr. Myron Craig
Gerson
● Organizational–American
Society of Nuclear
Cardiology
None None None None None None None
This table represents the relationships of peer reviewers with industry that were reported by the authors as relevant to this topic. It does not necessarily reflect relationships with industry at the time of
publication. *Names are listed in alphabetical order with each category of review.
Task Force 6: Training in Specialized
Electrophysiology, Cardiac Pacing,
and Arrhythmia Management
Endorsed by the Heart Rhythm Society
Gerald V. Naccarelli, MD, FACC, FHRS, Chair
Jamie B. Conti, MD, FACC, FHRS, John P. DiMarco, MD, PHD, FACC, FHRS,
Cynthia M. Tracy, MD, FACC, FHRS (Heart Rhythm Society Representative)
Clinical cardiac electrophysiology and cardiac pacing have
merged into a common cardiac subspecialty discipline. Com-
plex cardiac arrhythmias are managed by physicians with
special expertise in cardiac electrophysiology, the use of cardiac
implantable electrical devices (CIEDs), and the application of
other interventional ablative techniques and pharmacologic
treatments. Cardiac implantable electronic devices is a term
used to encompass implantable cardioverter-defibrillators
(ICDs), pacemakers, cardiac resynchronization therapy
(CRT) devices, implantable hemodynamic monitors
(IHMs), and implantable loop recorders (ILRs). For pur-
poses of this document, IHMs and ILRs, while legitimately
considered CIEDs, are excluded, and implantation numbers
for these should not be considered as satisfying minimum
training requirements.
The current Task Force is charged with updating previously
published adult clinical cardiac electrophysiology training
guidelines (1–4) based on changes in the cardiac electrophys-
iology field since the last revision (4). The number of proce-
dures recommended for each level is a consensus based on
published guidelines and competency statements and assumes
training by an appropriately trained mentor and documenta-
tion of satisfactory completion of such training by the program
director. The number of procedures and duration of training
are summarized in Tables 1 and 2.
General Standards and Environment
Facilities and Faculty
Three organizations—the American College of Cardiology
(ACC), the American Heart Association (AHA), and the
Heart Rhythm Society (HRS)—have addressed training
requirements and guidelines for permanent pacemaker se-
lection, implantation, and follow-up (5,6); guidelines for the
implantation and follow-up of ICDs in cardiovascular
practice (7,8); guidelines for training in catheter ablation
procedures (9,10); and teaching objectives for fellowship
programs in clinical electrophysiology (11,12). The training
recommendations for these 3 organizations are congruent
and address new technologies, faculty, and facility require-
ments, as well as practice. It is strongly recommended that
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